Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma
- 1 November 2009
- Vol. 11 (7) , 606-611
- https://doi.org/10.1111/j.1477-2574.2009.00110.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- Clinical utility of endoscopic ultrasound in solid pancreatic mass lesions deemed resectable by computer tomography.2008
- Predicting Unresectability in Pancreatic Cancer Patients: The Additive Effects of CT and Endoscopic UltrasoundJournal of Gastrointestinal Surgery, 2007
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Computed tomography, endoscopic, laparoscopic, and intra-operative sonography for assessing resectability of pancreatic cancerPublished by Elsevier ,2005
- Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic CancerAnnals of Surgical Oncology, 2005
- Comparison of Endoscopic Ultrasonography and Multidetector Computed Tomography for Detecting and Staging Pancreatic CancerAnnals of Internal Medicine, 2004
- Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the PancreasAnnals of Surgery, 2004
- Preoperative Staging and Tumor Resectability Assessment of Pancreatic Cancer: Prospective Study Comparing Endoscopic Ultrasonography, Helical Computed Tomography, Magnetic Resonance Imaging, and AngiographyAmerican Journal of Gastroenterology, 2004